Why the study?
Ischemic stroke may influence atherosclerotic plaque biology and recurrent cerebrovascular risk, yet how cerebral ischemia affects pre-existing atherosclerotic plaques through immune-metabolic remodeling remained incompletely understood.
Population
Sham-operated and stroke-operated mice with atherosclerotic plaques, plus human carotid endarterectomy specimens
Comparison
Sham-operated mice vs stroke mice without secondary ischemic lesions (Stroke-NR) vs stroke mice with secondary ischemic lesions (Stroke-R)
Design
Integrated multi-omics analysis combining single-cell transcriptomics, plasma metabolomics, spatial metabolomics, and immunofluorescence validation
Answers are grounded in this paper and cite their sources.
Should not alter post-stroke management; leaves open whether targeting the oxidized lipid–FABP5 axis reduces recurrent vascular events.
Ischemic stroke is increasingly recognized as a systemic inflammatory and metabolic insult that may influence atherosclerotic plaque biology and contribute to recurrent cerebrovascular risk. However, how cerebral ischemia affects pre-existing atherosclerotic plaques, particularly through immune–metabolic remodeling, remains incompletely understood. We integrated single-cell transcriptomic profiling of atherosclerotic plaques from sham-operated and stroke-operated mice with plasma metabolomics from sham-operated mice, stroke mice without secondary ischemic lesions (Stroke-NR), and stroke mice with secondary ischemic lesions (Stroke-R). Spatial metabolomic analysis of human carotid endarterectomy specimens and immunofluorescence validation were further performed to examine immune–metabolic alterations associated with plaque vulnerability. Single-cell RNA sequencing revealed stroke-associated remodeling of plaque cellular composition and macrophage states, including enrichment of FABP5-positive lipid-associated macrophages. Plasma metabolomics further identified a recurrence-associated metabolic signature. Mice with secondary ischemic lesions (Stroke-R) showed amplified circulating oxidized lipid remodeling. Spatial metabolomics of human carotid plaque sections showed preferential accumulation of 3-oxostearic acid within necrotic core regions of advanced plaques. Consistently, immunofluorescence staining showed FABP5 expression within CD68-positive macrophage-rich regions of lipid-rich necrotic plaques. These findings suggest that ischemic stroke is associated with plaque macrophage reprogramming, whereas stroke recurrence is accompanied by amplified circulating oxidized lipid remodeling. The combined 3-oxostearic acid and FABP5-positive macrophage findings define a candidate immune–metabolic signature that warrants further mechanistic validation.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: